Blue Cross, Blue Shield Sue Glaxo For Paxil Patent Gaming
Once again, GlaxoSmithKline has been accused of gaming the patent system to fend off generic competition for its popular antidepressant Paxil....To view the full article, register now.
Already a subscriber? Click here to view full article